Amendment No. 1 to License and Supply Agreement between Cephalon, Inc. and Barr Laboratories, Inc.
Cephalon, Inc. and Barr Laboratories, Inc. have agreed to amend their License and Supply Agreement dated July 7, 2004. The amendment changes the definition of the "Barr-Cephalon License Effective Date" to now mean the "Consent Agreement Effective Date." All other terms of the original agreement remain unchanged. Both parties have signed to confirm their acceptance of this amendment.
Exhibit 10.1(b)
July 9, 2004
Barr Laboratories, Inc.
Two Quaker Road
P.O. Box 2900
Pomona, New York 10970
Attention: President
Re: Amendment No. 1 to License and Supply Agreement
Dear Sir:
This letter is to confirm our understanding concerning an amendment to be made with respect to the License and Supply Agreement dated as of July 7, 2004 (the Agreement), between Cephalon, Inc. (Cephalon) and Barr Laboratories, Inc. (Barr). All terms not otherwise defined herein are used as defined in the Agreement.
The Agreement is hereby amended as follows:
1. Section 1.21 of the Agreement, the Barr-Cephalon License Effective Date, is hereby deleted in its entirety and replaced with the following:
1.21 Barr-Cephalon License Effective Date means the Consent Agreement Effective Date.
2. Except as amended hereby, the Agreement remains in full force and effect.
If the foregoing accurately reflects your understanding as to these matters, please indicate your agreement in the space provided below, and return one fully-executed original to me.
| Very truly yours, | |||||
|
| |||||
|
| |||||
| CEPHALON, INC. | |||||
|
| |||||
|
| |||||
| By: | /s/ Paul Blake |
| |||
| Name: | Paul Blake, FRCP | ||||
| Title: | Sr. V.P., Clinical Research & | ||||
|
| Regulatory Affairs | ||||
|
| |||||
Acknowledged and agreed to by: |
| |||||
|
| |||||
BARR LABORATORIES, INC. |
| |||||
|
| |||||
By: | /s/ Frederick J. Killion |
|
| |||
Name: Frederick J. Killion |
| |||||
Title: Sr. VP and General Counsel |
| |||||
A-1